Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
8.60
0.00
(0.00%)
At close: February 28 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
184,925
184,925
3,599
-9,970
-8,078
Investing Cash Flow
-211,485
-211,485
-19
-10
-6
Financing Cash Flow
3,619
3,619
-2
22,175
19,141
End Cash Position
17,094
17,094
40,180
36,783
24,188
Income Tax Paid Supplemental Data
11,840
11,840
--
--
--
Capital Expenditure
-40
-40
-19
-10
-6
Issuance of Capital Stock
3,637
3,637
--
23,281
20,216
Repurchase of Capital Stock
-18
-18
-2
-1,106
-1,075
Free Cash Flow
184,885
184,885
3,580
-9,980
-8,084
12/31/2020 - 11/4/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VALN Valneva SE
6.75
-5.20%
VRDN Viridian Therapeutics, Inc.
15.53
+1.57%
CHRO Channel Therapeutics Corporation
2.0500
0.00%
NGNE Neurogene Inc.
17.69
+3.45%
ASND Ascendis Pharma A/S
156.58
+2.25%
MRUS Merus N.V.
47.09
+1.88%
KALV KalVista Pharmaceuticals, Inc.
11.40
+6.59%
IGC IGC Pharma, Inc.
0.2900
+2.80%
TELO Telomir Pharmaceuticals, Inc.
4.0000
+2.30%
SCPH scPharmaceuticals Inc.
3.2800
+1.23%